Market closed
Usana Health Sciences/$USNA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Usana Health Sciences
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.
Ticker
$USNA
Sector
Trading on
NYSE
Industry
Personal Care Products
Headquarters
Employees
1,700
Website
USNA Metrics
BasicAdvanced
$510M
12.32
$2.19
0.98
-
Price and volume
Market cap
$510M
Beta
0.98
52-week high
$49.78
52-week low
$26.19
Average daily volume
257K
Financial strength
Current ratio
2
Quick ratio
1.302
Long term debt to equity
1.738
Total debt to equity
3.923
Interest coverage (TTM)
236.03%
Management effectiveness
Return on assets (TTM)
6.75%
Return on equity (TTM)
7.76%
Valuation
Price to earnings (TTM)
12.315
Price to revenue (TTM)
0.605
Price to book
0.97
Price to tangible book (TTM)
2.18
Price to free cash flow (TTM)
10.118
Growth
Revenue change (TTM)
-7.22%
Earnings per share change (TTM)
-33.64%
3-year revenue growth (CAGR)
-10.36%
3-year earnings per share growth (CAGR)
-27.43%
What the Analysts think about USNA
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Usana Health Sciences stock.
USNA Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
USNA Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
USNA News
AllArticlesVideos
USANA Health Sciences, Inc. (USNA) Q4 2024 Earnings Conference Call Transcript
Seeking Alpha·1 month ago
USANA Schedules Fourth Quarter and Fiscal Year 2024 Earnings Release and Conference Call
Business Wire·2 months ago
USANA Health Sciences to Participate in the 27th Annual ICR Conference
Business Wire·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Usana Health Sciences stock?
Usana Health Sciences (USNA) has a market cap of $510M as of April 02, 2025.
What is the P/E ratio for Usana Health Sciences stock?
The price to earnings (P/E) ratio for Usana Health Sciences (USNA) stock is 12.32 as of April 02, 2025.
Does Usana Health Sciences stock pay dividends?
No, Usana Health Sciences (USNA) stock does not pay dividends to its shareholders as of April 02, 2025.
When is the next Usana Health Sciences dividend payment date?
Usana Health Sciences (USNA) stock does not pay dividends to its shareholders.
What is the beta indicator for Usana Health Sciences?
Usana Health Sciences (USNA) has a beta rating of 0.98. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.